The Clorox Company (NYSE:CLX) Holdings Decreased by First National Bank of Mount Dora Trust Investment Services

First National Bank of Mount Dora Trust Investment Services cut its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 55.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,932 shares of the company's stock after selling 3,666 shares during the quarter. First National Bank of Mount Dora Trust Investment Services' holdings in Clorox were worth $478,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. QRG Capital Management Inc. bought a new position in shares of Clorox during the third quarter valued at about $225,000. Asset Management One Co. Ltd. increased its stake in shares of Clorox by 0.7% during the third quarter. Asset Management One Co. Ltd. now owns 82,210 shares of the company's stock valued at $13,393,000 after purchasing an additional 593 shares in the last quarter. Intact Investment Management Inc. purchased a new position in shares of Clorox in the 3rd quarter worth about $75,000. Van ECK Associates Corp lifted its position in Clorox by 2.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock valued at $237,372,000 after acquiring an additional 31,510 shares in the last quarter. Finally, Latitude Advisors LLC bought a new stake in shares of Clorox in the third quarter worth approximately $231,000. Institutional investors own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on CLX shares. Citigroup increased their price target on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Jefferies Financial Group raised Clorox from a "hold" rating to a "buy" rating and upped their target price for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. TD Cowen began coverage on Clorox in a research note on Tuesday, July 23rd. They set a "sell" rating and a $122.00 price target for the company. JPMorgan Chase & Co. upped their price objective on Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a research report on Friday, October 11th. Finally, Barclays lifted their target price on Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research report on Friday. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $151.57.

Clorox Stock Performance

Clorox stock traded down $0.90 during mid-day trading on Monday, reaching $162.21. 736,941 shares of the company were exchanged, compared to its average volume of 1,240,911. The firm's 50-day simple moving average is $161.48 and its two-hundred day simple moving average is $146.19. The Clorox Company has a twelve month low of $125.46 and a twelve month high of $169.09. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.63 and a current ratio of 1.00. The firm has a market cap of $20.08 billion, a PE ratio of 56.87, a price-to-earnings-growth ratio of 3.09 and a beta of 0.41.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the business posted $0.49 earnings per share. The firm's revenue for the quarter was up 27.0% compared to the same quarter last year. Equities analysts predict that The Clorox Company will post 6.79 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.01%. Clorox's dividend payout ratio (DPR) is presently 170.04%.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.57% of the stock is currently owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.